PRTG Portage Biotech Inc.

Portage Biotech is a unique entity in the world of biotechnology, catalyzing R&D to produce more quality clinical programs and maximize potential returns. We do this by leveraging our development strategy and commercial insights, capitalizing on a deep network of industry relationships, and by eliminating typical overhead costs associated with many biotechnology companies. The end result is a viable product development strategy that supports commercial potential and company growth. Our organization is comprised of scientists, clinicians, and pharma experienced executives who have combined their passion for innovation with broad business acumen, to create a better model for product development.

$12.60
As of 12/06/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  British Virgin Islands
IPO date:  02/25/2021
Outstanding shares:  13,326,213
Average volume:  32,375
Market cap:   $186,167,196
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    
ISIN:        VGG7185A1286
Sedol:      BMBT2L4
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.37
PS ratio:   0.00
Return on equity:   -14.73%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy